[go: up one dir, main page]

MX2013013243A - Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas. - Google Patents

Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas.

Info

Publication number
MX2013013243A
MX2013013243A MX2013013243A MX2013013243A MX2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A
Authority
MX
Mexico
Prior art keywords
methods
hydrostatic pressure
cancer
tumor cells
high hydrostatic
Prior art date
Application number
MX2013013243A
Other languages
English (en)
Inventor
Jirina Bartunková
Radek Spísek
Original Assignee
Sotio As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11172622A external-priority patent/EP2543386A1/en
Application filed by Sotio As filed Critical Sotio As
Publication of MX2013013243A publication Critical patent/MX2013013243A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se divulgan composiciones farmacéuticas para inducir una respuesta inmune contra células tumorales que comprenden células tumorales que se convierten en apoptóticas mediante tratamiento con presión hidrostática elevada y células dendríticas, y métodos para producir dichas composiciones.
MX2013013243A 2011-07-05 2012-07-04 Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas. MX2013013243A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161504387P 2011-07-05 2011-07-05
EP11172622A EP2543386A1 (en) 2011-07-05 2011-07-05 Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure
PCT/EP2012/062950 WO2013004708A1 (en) 2011-07-05 2012-07-04 Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells

Publications (1)

Publication Number Publication Date
MX2013013243A true MX2013013243A (es) 2014-05-30

Family

ID=50023029

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013243A MX2013013243A (es) 2011-07-05 2012-07-04 Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas.

Country Status (7)

Country Link
JP (1) JP6235085B2 (es)
CL (1) CL2013003282A1 (es)
CY (1) CY1115803T1 (es)
HR (1) HRP20141230T1 (es)
IL (2) IL229702A (es)
MX (1) MX2013013243A (es)
ZA (1) ZA201307886B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2852672C (en) 2011-10-17 2021-07-20 Massachusetts Institute Of Technology A microfluidic system and method for delivering a payload into a cell by causing perturbations in a cell membrane of the cell
JP6502940B2 (ja) 2013-08-16 2019-04-17 マサチューセッツ インスティテュート オブ テクノロジー 細胞への物質の選択的送達
AU2015338893A1 (en) 2014-10-31 2017-05-04 Massachusetts Institute Of Technology Delivery of biomolecules to immune cells
CN113897285A (zh) 2014-11-14 2022-01-07 麻省理工学院 化合物和组合物向细胞中的破坏和场实现的递送
AU2016206870B2 (en) 2015-01-12 2022-02-17 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
CN107922911A (zh) 2015-07-09 2018-04-17 麻省理工学院 将物质递送至无核细胞

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056834A2 (en) * 1998-02-20 2000-12-06 The Rockefeller University Apoptotic cell-mediated antigen presentation to dendritic cells
WO2006095330A2 (en) * 2005-03-10 2006-09-14 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases

Also Published As

Publication number Publication date
CY1115803T1 (el) 2017-01-25
HRP20141230T1 (hr) 2015-02-13
IL229702A0 (en) 2014-01-30
JP2017025066A (ja) 2017-02-02
IL229702A (en) 2016-09-29
IL247781A0 (en) 2016-11-30
CL2013003282A1 (es) 2014-10-10
IL247781B (en) 2019-11-28
JP6235085B2 (ja) 2017-11-22
ZA201307886B (en) 2015-03-25

Similar Documents

Publication Publication Date Title
PH12013502462B1 (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
MX2019010269A (es) Arn terapeutico.
PH12017500787A1 (en) Methods of selecting t cell line and donor thereof for adoptive cellular therapy
NZ739133A (en) Cellular targeted active ingredient delivery system
MX2022003698A (es) Composiciones de nanoparticulas y metodos para inmunoterapia.
WO2014028453A3 (en) Natural killer cells and uses thereof
AR082340A1 (es) Metodos y composiciones para la terapia del cancer de higado
MY197851A (en) Antibody formulations
MX2018002166A (es) Conjugados anticuerpo anti-dll3-farmaco y metodos de uso.
BR112014022562A8 (pt) Formulação de rna para imunoterapia
MX2022012013A (es) Composiciones y metodos para transduccion de tumores.
PH12017500406A1 (en) Novel anti-mfi2 antibodies and methods of use
MX359769B (es) Metodos para descelularizar huesos.
MX2013013243A (es) Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas.
MX2018006249A (es) Nuevos anticuerpos anti-emr2 y metodos de uso.
EP4552698A3 (en) Methods of treating prostate cancer
EP3998341A3 (en) Adenoviral vectors
MX375994B (es) Composicion farmaceutica que comprende particulas de plga-peg.
EP4233896A3 (en) Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
AU2014249346A8 (en) High purity ovarian cancer stem cells for active autologous immune therapy
EP4321218A3 (en) Cancer stem cell targeted cancer vaccines
MX2013003859A (es) Polimorfos de picropodofilina b o c para su uso en la terapia del cancer.
TH149241A (th) วิถีทาง และวิธีสำหรับแอคทีฟ เซลลูลาร์ อิมมูโนเธราปี เพื่อรักษาโรคมะเร็งโดยการใช้เซลล์เนื้องอกซึ่งถูกฆ่าโดยแรงดันไฮโดรสแทติคระดับสูง และเซลล์เดนไดรท์
MX350868B (es) Medicamentos y metodos para tratar cancer.

Legal Events

Date Code Title Description
FG Grant or registration